Dymind Information

Dymind is an enterprise driven by innovation, the number of R&D staff accounts for over 40%, the annual R&D expenditure exceeds 20% of revenue. Dymind has a national-level blood cells reference measurement laboratory approved by CNAS. Dymind has applied for more than 500 national-level patents since establishment and all products have been approved by the international authority quality management system. As a doctoral workstation of Guangdong Province, Dymind established a series of school-enterprise scientific research and training bases with Shenzhen University and Southern Medical University. As a innovator of joint detection of blood routine item and specific protein, Dymind launched its self-developed joint detection analyzers, including blood routine and CRP joint detection analyzers, the world's leading 5-Part and 3-Part joint detection hematology analyzers, automatic blood routine and CRP joint detection analyzers consuming less blood sample and joint detection analyzers for blood routine, CRP and SAA, which promote the new breakthrough of hematology analysis equipment, and further improve the diagnosis and treatment efficiency of medical institutions. Dymind always implements the concept of customer-focused, takes the customer demands as the highest purpose. In Dymind, the products quality is strictly controlled thorough the whole process of manufacturing, the product line is expanded rapidly. In the competition with the domestic brands, Dymind holds an increasing market share, which steady ranks second in the blood testing market. Nowadays, Dymind's products and service have been spread over 120 countries and regions around the world. Through increasingly sophisticated joint detection solutions and high quality products and services for clinical diagnosis, Dymind is always taking care of health with medical innovation. 20 %